NYSE:HUM • US4448591028
The current stock price of HUM is 173.62 USD. Today HUM is down by -2.75%. In the past month the price decreased by -8.38%. In the past year, price decreased by -31.34%.
ChartMill assigns a technical rating of 0 / 10 to HUM. When comparing the yearly performance of all stocks, HUM is a bad performer in the overall market: 90.36% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to HUM. There are concerns on the financial health of HUM while its profitability can be described as average.
On February 11, 2026 HUM reported an EPS of -3.96 and a revenue of 36.64B. The company beat EPS expectations (2.11% surprise) and beat revenue expectations (13.08% surprise).
33 analysts have analysed HUM and the average price target is 237.71 USD. This implies a price increase of 36.92% is expected in the next year compared to the current price of 173.62.
For the next year, analysts expect an EPS growth of -45.96% and a revenue growth 23.64% for HUM
Over the last trailing twelve months HUM reported a non-GAAP Earnings per Share(EPS) of 17.13. The EPS increased by 5.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.92% | ||
| ROA | 2.43% | ||
| ROE | 6.73% | ||
| Debt/Equity | 0.7 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 15.66 | 255.755B | ||
| ELV | ELEVANCE HEALTH INC | 10.81 | 62.387B | ||
| CNC | CENTENE CORP | 11.98 | 17.9B | ||
| MOH | MOLINA HEALTHCARE INC | 18.17 | 7.278B | ||
| HQY | HEALTHEQUITY INC | 17.1 | 6.707B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | 40.56 | 3.698B | ||
| PGNY | PROGYNY INC | 17 | 1.467B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.044B |
View all stocks in the Managed Health Care Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 67,060 full-time employees. The firm's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
IPO: 1971-05-18
HUMANA INC
101 E. Main Street
Louisville KENTUCKY 40202 US
CEO: Bruce D. Broussard
Employees: 65680
Phone: 13026587581
Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 67,060 full-time employees. The firm's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
The current stock price of HUM is 173.62 USD. The price decreased by -2.75% in the last trading session.
HUMANA INC (HUM) has a dividend yield of 1.96%. The yearly dividend amount is currently 3.57.
HUM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
HUM stock is listed on the New York Stock Exchange exchange.
33 analysts have analysed HUM and the average price target is 237.71 USD. This implies a price increase of 36.92% is expected in the next year compared to the current price of 173.62.
HUMANA INC (HUM) will report earnings on 2026-04-29, before the market open.